Integrated Diagnostics Holdings PLC (OTCPK:IDGXF)
$ 0.49 (0%) Market Cap: 299.38 Mil Enterprise Value: 304.79 Mil PE Ratio: 31.88 PB Ratio: 4.18 GF Score: 49/100

Full Year 2024 Integrated Diagnostics Holdings PLC Earnings Call Transcript

Apr 17, 2025 / 01:00PM GMT
Release Date Price: $0.322

Key Points

Positve
  • Integrated Diagnostics Holdings PLC (IDGXF) achieved a record-breaking 39% year-on-year revenue growth, reaching EGP5.7 billion.
  • The company performed 39.2 million tests in 2024, marking a five-year compounded annual growth rate of 12% in conventional test volume.
  • The test per patient metric improved to 4.4 tests per patient in 2024, up from 4.2 in 2023 and 3.7 in 2022.
  • The company expanded its network in Egypt by adding 43 new branches, maintaining its position as the largest diagnostic provider in the country.
  • Profitability improved across gross profit, EBITDA, and net profit levels, despite rising cost pressures from inflation and currency devaluation.
Negative
  • Macroeconomic difficulties in Egypt and Nigeria, along with geopolitical instability in the MENA region, posed significant challenges.
  • The ongoing conflict in Sudan severely impacted operations, with only one branch operational for several months.
  • The company deferred its dividend declaration for 2024, causing disappointment among investors.
  • Audit expenses increased due to the devaluation of the Egyptian pound, despite delisting from the Egyptian exchange.
  • The rollout of the Saudi Arabian venture was slower than expected, impacting the anticipated growth trajectory.
Ahmed Moataz
EFG Hermes - Analyst

Hello, everyone. This is Ahmed Moataz from EFG Hermes and welcome to IDH's 2024 results conference call. I'm pleased to be joined with Dr. Hend El Sherbini, Chief Executive Officer; Sherif El Zeiny, Chief Financial Officer; and Tarek Yehia, Director of Investor Relations.

As usual, the company will start with a brief update on recent results and guidance, and then we'll open the floor for Q&A. Tarek, please go ahead.

Tarek Yehia
Integrated Diagnostics Holdings PLC - Director of Investor Relations

Good afternoon, ladies and gentlemen, and thank you, Ahmed for joining us and hosting the call today. My name is Tarek Yehia, and I'm IDH Investor Relations Director. Joining me today, Dr. Hend El Sherbini, our CEO; and Mr. Sherif El Zeiny, our Group CFO and VP.

Dr. Hend will begin the call with a summary of the year main highlights. After that, I will discuss in more detail the main macroeconomics and geopolitical trends seen across our markets. We will then open the floor for our questions. With that, I will

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot